mBerry for Taste Disturbance
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests mBerry tablets to address taste issues in head and neck cancer patients undergoing radiation therapy. The goal is to determine if mBerry can enhance taste, making meals more enjoyable and helping patients maintain better nutrition. Participants will either take mBerry tablets daily for two meals or join a group that does not take mBerry, with both groups undergoing regular taste check-ups. This trial suits adults with specific head or neck cancers who are currently receiving radiation therapy and have not undergone major surgeries like a total glossectomy (removal of the tongue). As an unphased trial, this study provides a unique opportunity to explore a potential new way to improve quality of life during treatment.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are taking Metformin, you cannot participate.
What prior data suggests that mBerry is safe for use in head and neck cancer patients?
Research has shown that mBerry, derived from the miracle berry, is generally safe for people. In a small study with 23 patients experiencing taste problems from chemotherapy, consuming this berry proved safe, with no major side effects reported.
Although the FDA has not approved mBerry for treating taste issues from radiation, it has been used safely in other contexts. Researchers are investigating its potential to improve taste after radiation therapy in cancer patients.
Overall, early studies suggest that mBerry is well-tolerated, meaning most people can take it without issues. However, as with any treatment, monitoring for any unusual reactions is important.12345Why are researchers excited about this trial?
Researchers are excited about mBerry for taste disturbances because it offers a natural, fruit-derived solution that could be more appealing to patients than traditional synthetic treatments. Unlike standard care options that might focus on altering taste perception through chemical means, mBerry works by using miraculin, a glycoprotein found in the miracle fruit, which temporarily changes the way taste receptors interpret sour and bitter flavors, making them taste sweet instead. This unique approach not only provides a novel mechanism of action but also offers a safer, non-invasive alternative that could enhance the eating experience for those with taste disturbances.
What evidence suggests that mBerry might be an effective treatment for dysgeusia?
Research shows that the miracle berry, or mBerry, can enhance flavor enjoyment for those with taste problems. In this trial, participants in the experimental group will receive mBerry tablets. One study found that patients taking a food supplement made from miraculin, like mBerry, reported improved taste experiences. Another study discovered that people using mBerry could taste flavors more clearly over time. Additionally, patients often noticed positive changes in their taste after using miracle fruit. These findings suggest mBerry might improve taste for individuals with altered taste following cancer treatments.13678
Who Is on the Research Team?
Jennifer Larsson
Principal Investigator
University of South Florida
Are You a Good Fit for This Trial?
This trial is for adults over 18 with mandibular, tonsillar, or lingual cancer who are undergoing primary or adjuvant radiation therapy. It's designed to help those experiencing taste disturbances (dysgeusia) due to their treatment.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants undergo radiation therapy as part of their standard cancer treatment
Treatment
Participants receive mBerry tablets twice daily for 8 weeks to manage dysgeusia
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- mBerry
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Florida
Lead Sponsor